Brent GA. Clinical practice. Graves' disease. N Engl J Med. 2008;358:2594.
Trzepacz PT, Klein I, Robert, M, et al. Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms. Am J Med. 1989;87:558.
Nordyke RA, Gilbert FI Jr., Harada ASM. Graves' disease: influence of age on clinical findings. Arch Intern Med. 1988;148:626.
Franklyn JA. Drug therapy: the management of hyperthyroidism. N Engl J Med. 1994;330:1731.
Dale J, Daykin J, Holder R, et al. Weight gain following treatment of hyperthyroidism. Clin Endocrinol (Oxf). 2001;55:233.
Osman F, Franklyn JA, Holder RL, et al. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. J Am Coll Cardiol. 2007;49:71.
Villadolid MC, Yokoyama N, Izumi N, et al. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance imaging. J Clin Endocrinol Metab. 1995;80:2830.
Fatourechi V, Fransway AF. Dermopathy of Graves' disease (pretibial myxedema). Medicine. 1994;73:1.
Torring O, Tallstedt L, Wallin G, et al. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine -- a prospective, randomized study. J Clin Endocrinol Metab. 1996;81:2986.
Sridama V, McCormick M, Kaplan EL, et al. Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease. N Engl J Med. 1984;311:426.
Ron ER, Doody MM, Becker DV, et al. Cancer mortality following treatment for adult hyperthyroidism. JAMA. 1998;280:347.
Saenger EL, Thoma GE, Tompkins EA. Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-Up Study. JAMA. 1968;205:855.
Burch HB, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev. 1993;14:747.
Wiersinga WM, Prummel MF. An evidence-based approach to the treatment of Graves' ophthalmopathy. Endocrinol Metab Clin North Am. 2000;29:297.
Schwartz KM, Fatourechi V, Ahmed DD, Pond GR. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J Clin Endocrinol Metab. 2002;87:438.